Back

LDL-C treatment patterns and associated outcomes in patients with type 2 diabetes and CVD: insights from TECOS

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular risk and its modification Lipid-Lowering Agents ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Gaetano Maria De Ferrari

University of Turin, Turin (Italy)

5 More presentations in this session

Presentation thumbnail
Miss M. Schreuder (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Professor P. Meikle (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Professor S. Verma (Toronto, CA)
Abstract
Presentation thumbnail
Professor S. Bain (Swansea, GB)
Abstract Slides
Presentation thumbnail
Doctor D. Fitchett (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Cardiovascular risk and its modification

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Presentation
Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors
30 August 2025
thumbnail
Congress Presentation
LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study
27 August 2022
thumbnail
Webinar
Chronic kidney disease: a modifiable cardiovascular risk factor in patients with type 2 diabetes
25 October 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources